Shouyao Holdings Gets Approval for Lung Cancer Drug Study; Shares Drop 6%-- Shouyao Holdings Beijing obtained approval from China's National Medical Products Administration to hold clinical trials into the drug SY-3505 , which is used for the treatment of patients with...